Novanta Inc. (NOVT)
NASDAQ: NOVT · Real-Time Price · USD
135.66
+4.13 (3.14%)
Oct 20, 2026, 2:11 PM EDT - Market open
Novanta Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,030 | 980.6 | 949.25 | 881.66 | 860.9 | 706.79 |
Revenue Growth | 7.61% | 3.30% | 7.66% | 2.41% | 21.80% | 19.67% |
Gross Profit Gross Profit Growth | 458.68 | 435.28 | 424.32 | 399.9 | 378.63 | 301.74 |
Operating Income Operating Income Growth | 119.36 | 116.1 | 126.5 | 122.55 | 107.83 | 83.09 |
Net Income Net Income Growth | 61.76 | 53.83 | 64.09 | 72.88 | 74.05 | 50.33 |
Earnings Per Share EPS Growth | 1.58 | 1.47 | 1.77 | 2.02 | 2.06 | 1.41 |
EPS Growth | -6.40% | -16.95% | -12.38% | -1.94% | 46.10% | 12.80% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Automation Enabling Technologies Automation Enabling Technologies Growth | 523.46 | 500.84 | 490.62 | 499.22 | 534.09 |
Medical Solutions Medical Solutions Growth | 506.24 | 479.77 | 458.63 | 382.44 | 326.81 |
Revenue (Total) Revenue (Total) Growth | 1,030 | 980.6 | 949.25 | 881.66 | 860.9 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 718.65 | 380.87 | 113.99 | 105.05 | 100.11 | 117.39 |
Total Debt Total Debt Growth | 285.6 | 302.74 | 471 | 404.56 | 489.38 | 493.4 |
Net Cash (Debt) Net Cash Growth | 433.05 | 78.14 | -357.01 | -299.51 | -389.28 | -376.01 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 11.08 | 2.13 | -9.88 | -8.31 | -10.84 | -10.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 133.84 | 64.06 | 158.51 | 120.08 | 90.78 | 94.63 |
Capital Expenditures CapEx Growth | -19.56 | -15.63 | -17.16 | -19.96 | -19.64 | -19.98 |
Free Cash Flow Free Cash Flow Growth | 114.28 | 48.43 | 141.35 | 100.11 | 71.14 | 74.65 |
Free Cash Flow Growth | -3.04% | -65.74% | 41.19% | 40.74% | -4.71% | -42.45% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.55% | 44.39% | 44.70% | 45.36% | 43.98% | 42.69% |
Operating Margin | 11.59% | 11.84% | 13.33% | 13.90% | 12.53% | 11.76% |
Pretax Margin | 7.74% | 7.10% | 8.33% | 9.50% | 10.12% | 7.95% |
Profit Margin | 6.00% | 5.49% | 6.75% | 8.27% | 8.60% | 7.12% |
FCF Margin | 11.10% | 4.94% | 14.89% | 11.36% | 8.26% | 10.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 85.77 | 79.08 | 85.63 | 82.75 | 65.49 | 124.72 |
Forward PE | 34.01 | 32.87 | 44.41 | 58.24 | 42.36 | 60.23 |
P/FCF Ratio | 45.00 | 87.90 | 38.82 | 60.24 | 68.17 | 84.09 |
PS Ratio | 4.99 | 4.34 | 5.78 | 6.84 | 5.63 | 8.88 |